Inhibition of TGFβ plus immune checkpoint blockade led to Th1 CD4+ T cell responses and the clonal expansion of CD8+ T cells in bone tumors, which improved anti-tumor responses and increased survival in mice. This evidence concerns the gene CD8A and neoplasm.